Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alkermes Plc (ALKS): Are Hedge Funds Right About This Stock?

Page 1 of 2

We at Insider Monkey have gone over 742 13F filings that hedge funds and prominent investors are required to file by the government. The 13F filings show the funds’ and investors’ portfolio positions as of September 30. In this article, we look at what those funds think of Alkermes Plc (NASDAQ:ALKS) based on that data.

Alkermes Plc (NASDAQ:ALKS) was in 22 hedge funds’ portfolios at the end of the third quarter of 2016. ALKS shareholders have witnessed a decrease in enthusiasm from smart money of late. There were 25 hedge funds in our database with ALKS holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as IDEX Corporation (NYSE:IEX), Trimble Navigation Limited (NASDAQ:TRMB), and The Middleby Corporation (NASDAQ:MIDD) to gather more data points.

Follow Alkermes Plc. (NASDAQ:ALKS)
Trade (NASDAQ:ALKS) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

RAJ CREATIONZS / shutterstock.com

How are hedge funds trading Alkermes Plc (NASDAQ:ALKS)?

At Q3’s end, a total of 22 of the hedge funds tracked by Insider Monkey were long this stock, down by 12% from the second quarter of 2016. By comparison, 34 hedge funds held shares or bullish call options in ALKS heading into this year. With hedgies’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

HedgeFundSentimentChart (42)

When looking at the institutional investors followed by Insider Monkey, Neil Woodford’s Woodford Investment Management has the biggest position in Alkermes Plc (NASDAQ:ALKS), worth close to $355 million, corresponding to 14.4% of its total 13F portfolio. Coming in second is D E Shaw, which holds a $78.3 million position. Some other peers that hold long positions encompass Stephen DuBois’ Camber Capital Management, and Phill Gross and Robert Atchinson’s Adage Capital Management. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2